Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001019687-15-003780
Filing Date
2015-10-23
Accepted
2015-10-23 10:36:06
Documents
18
Period of Report
2014-08-31

Document Format Files

Seq Description Document Type Size
1 CANNABICS PHARMACEUTICALS INC. cnbx_10ka-083114.htm 10-K/A 374530
2 BYLAWS OF CANNABICS PHARMACEUTICALS INC. cnbx_10ka-ex0302.htm EX-3.2 112347
3 SUBSIDIARY BOARD RESOLUTION AUTHORIZING CREATION cnbx_10ka-ex0303.htm EX-3.3 4810
4 SUBSIDIARYOFFICIAL COMPANIES LISTING cnbx_10ka-ex0304.htm EX-3.4 445
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, cnbx_10ka-ex3101.htm EX-31.1 9887
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, cnbx_10ka-ex3102.htm EX-31.2 9852
7 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cnbx_10ka-ex3201.htm EX-32.1 4598
8 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cnbx_10ka-ex3202.htm EX-32.2 4397
9 GRAPHIC signature.jpg GRAPHIC 4208
10 GRAPHIC accountant_logo.jpg GRAPHIC 6448
11 GRAPHIC image_001.jpg GRAPHIC 8358
12 GRAPHIC cnbx_10ka-ex0304.jpg GRAPHIC 55945
  Complete submission text file 0001019687-15-003780.txt   1863286

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE cnbx-20140831.xml EX-101.INS 185818
14 XBRL SCHEMA FILE cnbx-20140831.xsd EX-101.SCH 16807
15 XBRL CALCULATION FILE cnbx-20140831_cal.xml EX-101.CAL 33876
16 XBRL DEFINITION FILE cnbx-20140831_def.xml EX-101.DEF 30086
17 XBRL LABEL FILE cnbx-20140831_lab.xml EX-101.LAB 131419
18 XBRL PRESENTATION FILE cnbx-20140831_pre.xml EX-101.PRE 101332
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52403 | Film No.: 151172038
SIC: 1000 Metal Mining